These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bidil: recontextualizing the race debate. Séguin B; Hardy B; Singer PA; Daar AS Pharmacogenomics J; 2008 Jun; 8(3):169-73. PubMed ID: 18195727 [No Abstract] [Full Text] [Related]
7. Colour-coded cures. Kingsland J New Sci; 2005 Jun 11-17; 186(2503):42-7. PubMed ID: 16178100 [No Abstract] [Full Text] [Related]
8. Nitroso-redox balance in the cardiovascular system. Hare JM N Engl J Med; 2004 Nov; 351(20):2112-4. PubMed ID: 15533853 [No Abstract] [Full Text] [Related]
9. BiDil for heart failure in black patients. Kahn JD Ann Intern Med; 2007 Aug; 147(3):215; author reply 215-6. PubMed ID: 17679713 [No Abstract] [Full Text] [Related]
10. BiDil for heart failure in black patients. Bibbins-Domingo K; Fernandez A Ann Intern Med; 2007 Aug; 147(3):214-5; author reply 215-6. PubMed ID: 17679712 [No Abstract] [Full Text] [Related]
11. FDA approves heart drug for black patients. Meadows M FDA Consum; 2005; 39(5):8-9. PubMed ID: 16419285 [TBL] [Abstract][Full Text] [Related]
12. BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective. Temple R; Stockbridge NL Ann Intern Med; 2007 Jan; 146(1):57-62. PubMed ID: 17200223 [TBL] [Abstract][Full Text] [Related]
13. Using race in clinical research to develop tailored medications. Is the FDA encouraging discrimination or eliminating traditional disparities in health care for African Americans? Ruel MD J Leg Med; 2006 Jun; 27(2):225-41. PubMed ID: 16728354 [No Abstract] [Full Text] [Related]
14. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. Taylor AL; Ziesche S; Yancy C; Carson P; D'Agostino R; Ferdinand K; Taylor M; Adams K; Sabolinski M; Worcel M; Cohn JN; N Engl J Med; 2004 Nov; 351(20):2049-57. PubMed ID: 15533851 [TBL] [Abstract][Full Text] [Related]
15. What's right (and wrong) with racially stratified research and therapies. Sade RM J Natl Med Assoc; 2007 Jun; 99(6):693-6. PubMed ID: 17595943 [No Abstract] [Full Text] [Related]
16. The impact of race on response to RAAS inhibition. Wallace TW; Drazner MH Curr Heart Fail Rep; 2005 Aug; 2(2):72-7. PubMed ID: 16036054 [TBL] [Abstract][Full Text] [Related]
17. Color blind, or just plain blind? Czap A Altern Med Rev; 2005 Jun; 10(2):81-2. PubMed ID: 16032786 [No Abstract] [Full Text] [Related]
18. Drug success signals a new trend. A "race-based" medication is a step toward individualized care. Heart Advis; 2005 Apr; 8(4):4-5. PubMed ID: 16138392 [No Abstract] [Full Text] [Related]